| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $272.6M | — | -76.8% |
| R&D Expense | $100.9M | — | -7.4% |
| SG&A Expense | $86.2M | — | +6.5% |
| Operating Income | $45.0M | — | -95.4% |
| Pre-tax Income | -$2.5M | — | -100.3% |
| Income Tax | $347K | — | -99.5% |
| Net Income | -$2.8M | — | -100.3% |
| EPS (Basic) | -$0.03 | — | -100.3% |
| EPS (Diluted) | -$0.03 | — | -100.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $834.0M | -15.3% | -43.7% |
| Short-term Investments | $1.06B | +10.2% | +93.5% |
| Accounts Receivable | $219.9M | +21.1% | +4.5% |
| Inventory | $75.6M | -5.1% | +248.6% |
| Current Assets | $2.25B | -0.9% | -2.7% |
| Total Assets | $2.87B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$59.0M | — | -106.8% |
| Capital Expenditures | $1.2M | — | -30.6% |
| Investing Cash Flow | -$93.7M | — | +49.2% |
| Financing Cash Flow | $6.4M | — | -32.0% |
| Free Cash Flow | -$60.2M | — | -106.9% |
| +8.0% |
| Current Liabilities | $923.6M | -4.6% | +55.1% |
| Total Liabilities | $3.05B | -1.8% | +7.3% |
| Stockholders' Equity | -$180.5M | +12.1% | +2.9% |